Total Funding
53
Total FundingSeries B raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.
Lorenzo Pellegrini: CEO & founderPast Role: Cyrenaic Pharmaceuticals, Director- Neil Shusterman: Chief Medical Officer
About the Company
Palladio Bio is a clinical-stage company developing transformative medicines for orphan diseases of the kidney. The company specializes in the fields of biotechnology, pharmaceutical. and therapeutics.
Its products are designed for renal disease, kidney disease, and polycystic kidney disease.
The company was founded in 2015 and headquartered in
Horsham, Pennsylvania.
